Malihe Moghadam
Overview
Explore the profile of Malihe Moghadam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jomehpour N, Sankian M, Soleimanpour S, Derakhshan M, Ghazvini K, Pordel S, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2025 Mar;
43(3):148-155.
PMID: 40037743
Introduction: Gold nanoparticles (GNPs) are chemically inert, have low toxicity, and are easy to modify and functionalize for the detection of many pathogens. They have excellent immune modulatory and adjuvant...
2.
Haghnavaz N, Rezaee M, Pordel S, Shobeiri S, Dashti M, Ansari B, et al.
Immunopharmacol Immunotoxicol
. 2024 Oct;
46(6):815-828.
PMID: 39376102
Objective: One of the most effective treatments for allergic respiratory diseases is allergen-specific sublingual immunotherapy (SLIT). While, mannose targeting has been applied in various immunostimulatory approaches, but it has not...
3.
Emami Z, Shobeiri S, Khorrami R, Haghnavaz N, Rezaee M, Moghadam M, et al.
Mediators Inflamm
. 2024 Jul;
2024:5821996.
PMID: 39045230
Background: Psoriasis is a noncontagious auto-inflammatory chronic skin disease. So far, some of the inflammatory genes were upregulated in mouse model of psoriasis. This study examined changes in skin mRNA...
4.
Rezaee M, Shobeiri S, Moghadam M, Mashayekhi K, Sankian M
J Pharm Biomed Anal
. 2024 May;
247:116245.
PMID: 38810331
Interleukin (IL)-23 inhibitor monoclonal antibodies shown significant efficacy in treating autoimmune diseases. DNA or RNA aptamers exhibit comparable specificity to antibodies, are cost-effective, non-immunogenic, and do not have batch to...
5.
Ansari B, Abbaspour M, Estajy A, Haghnavaz N, Pordel S, Rezaee M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 May;
397(10):7839-7856.
PMID: 38743115
Curcumin (CUR) has been considered a potential therapeutic agent for allergic reactions due to its antioxidant and anti-inflammatory activities. Nanofibers have attracted increasing attention in drug delivery. The aim of...
6.
Pordel S, Rezaee M, Moghadam M, Sankian M
Immunol Invest
. 2024 Jan;
53(3):523-539.
PMID: 38166585
Background: The rapid uptake of antigens by antigen-presenting cells (APCs) and their migration to draining lymph nodes in the initial hours after antigen administration in epicutaneous allergen specific immunotherapy (EPIT)...
7.
Pordel S, Haghnavaz N, Rezaee M, Shobeiri S, Ansari B, Dashti M, et al.
Immunol Res
. 2023 Dec;
72(3):460-475.
PMID: 38091227
Background: Gold nanoparticles (GNPs) have previously been suggested as appropriate carriers for allergen-specific immunotherapy (AIT). In this study, we assessed efficacy of GNPs and dendritic cells (DC)-specific aptamer-modified GNPs (Apts-GNP)...
8.
Shobeiri S, Dashti M, Pordel S, Rezaee M, Haghnavaz N, Moghadam M, et al.
Cytokine
. 2023 Oct;
172:156406.
PMID: 37879125
Background: Tumor Necrosis Factor-α (TNF-α) is a pro-inflammatory factor that plays a pivotal role in psoriasis. Due to limitations of monoclonal antibody-based therapies, it is needed to discover new anti-TNF-α...
9.
Shobeiri S, Mashayekhi K, Khorrami M, Moghadam M, Sankian M
Biochem Biophys Res Commun
. 2022 Nov;
637:32-39.
PMID: 36375248
Background: Interleukin-17A (IL-17A) is an important pro-inflammatory cytokine observed in the development of many disorders, such as psoriasis, rheumatoid arthritis, and multiple sclerosis. The anti-IL-17A biological drugs, including Secukinumab, Ixekizumab,...
10.
Shobeiri S, Rezaee M, Pordel S, Haghnnavaz N, Dashti M, Moghadam M, et al.
Int Immunopharmacol
. 2022 Jun;
110:108963.
PMID: 35724603
Objectives: IL-17 is an important player in the psoriasis pathogenesis, which recruits inflammatory cells to the psoriatic lesions, induced keratinocyte proliferation and plaque formation. Three monoclonal antibodies that block IL-17...